14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $189.44 $218.86 Friday, 3rd May 2024 BIIB stock ended at $217.51. This is 1.87% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.24% from a day low at $213.11 to a day high of $217.88.
90 days $189.44 $246.44
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Jan 18, 2022 $238.90 $238.90 $231.37 $233.81 1 631 500
Jan 14, 2022 $235.08 $239.47 $233.80 $239.30 1 767 600
Jan 13, 2022 $225.30 $239.64 $225.30 $236.67 3 781 400
Jan 12, 2022 $223.10 $227.59 $217.10 $225.34 7 511 100
Jan 11, 2022 $235.40 $243.71 $235.00 $241.52 1 557 700
Jan 10, 2022 $232.75 $235.55 $230.54 $235.31 1 754 000
Jan 07, 2022 $235.55 $236.90 $231.62 $232.60 1 394 900
Jan 06, 2022 $240.30 $242.45 $236.85 $237.30 1 036 900
Jan 05, 2022 $241.73 $249.00 $239.18 $239.27 1 167 400
Jan 04, 2022 $245.13 $245.45 $239.00 $241.73 1 277 219
Jan 03, 2022 $240.15 $247.51 $238.07 $244.14 1 640 647
Dec 31, 2021 $239.76 $243.71 $239.50 $239.92 1 531 089
Dec 30, 2021 $245.19 $247.00 $237.05 $240.00 4 418 675
Dec 29, 2021 $235.00 $265.54 $234.13 $258.31 6 793 247
Dec 28, 2021 $233.34 $236.96 $233.02 $235.99 761 617
Dec 27, 2021 $235.23 $236.70 $232.36 $234.19 1 742 924
Dec 23, 2021 $232.95 $236.21 $232.04 $235.41 1 003 269
Dec 22, 2021 $236.26 $236.48 $231.29 $234.48 783 315
Dec 21, 2021 $235.05 $237.60 $230.05 $234.65 1 030 215
Dec 20, 2021 $239.75 $240.00 $234.25 $236.96 1 127 714
Dec 17, 2021 $233.00 $239.90 $232.58 $237.43 2 267 426
Dec 16, 2021 $237.29 $243.43 $234.86 $235.52 1 252 236
Dec 15, 2021 $230.20 $236.37 $228.95 $235.88 1 262 400
Dec 14, 2021 $233.93 $236.63 $230.17 $230.76 1 232 546
Dec 13, 2021 $231.68 $235.80 $230.18 $234.50 1 236 639
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT